Periocular squamous cell carcinoma

Dermatologic Surgery

Volumn 34, Issue 5, 2008, Pages 585-599

  Thosani, Maya K ^a,b   Schneck, Gideon ^a   Jones, Evan C ^a  

^a STONY BROOK UNIVERSITY MEDICAL CENTER   (United States)

^b Stony Brook Dermatology Associates   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANAMNESIS; CANCER INCIDENCE; CANCER MORTALITY; CHEMOSURGERY; CLINICAL EXAMINATION; CLINICAL FEATURE; DIAGNOSTIC IMAGING; HUMAN; METASTASIS; MINIMALLY INVASIVE SURGERY; PATHOGENESIS; PHYSICAL EXAMINATION; PREVALENCE; PRIORITY JOURNAL; REVIEW; SQUAMOUS CELL CARCINOMA; TUMOR BIOPSY; AGED; CANCER INVASION; CASE REPORT; EYE SURGERY; EYELID TUMOR; FEMALE; FROZEN SECTION; LYMPH NODE METASTASIS; MULTIMODALITY CANCER THERAPY; PATHOLOGY; SKIN TUMOR; TUMOR RECURRENCE;

AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; EYELID NEOPLASMS; FEMALE; FROZEN SECTIONS; HUMANS; LYMPHATIC METASTASIS; MOHS SURGERY; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; OPHTHALMOLOGIC SURGICAL PROCEDURES; SKIN NEOPLASMS;

EID: 42449121720     PISSN: 10760512     EISSN: 15244725     Source Type: Journal    
DOI: 10.1111/j.1524-4725.2007.34115.x     Document Type: Review

References (75)

1. Leibovitch I, Huilgol S, Selva D, et al. Cutaneous squamous cell carcinoma treated with Mohs micrographic surgery in Australia. I. Experience over 10 years. J Am Acad Dermatol 2005 53: 253 60.
2. Rowe DE, Carroll RJ, Day CL. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection. Am Acad Dermatol 1992 26:976 90.
3. Malhotra R, Huilgol S, Huynh N, et al. Australian mohs database periocular squamous cell carcinoma. Ophthalmology 2004 111:617 23.
4. Meads S, Greenway H. Basal cell carcinoma associated with orbital invasion: clinical features and treatment options. Dermatol Surg 2006 32:442 6.
5. Cook BE, Bartley GB. Treatment options and future prospects for the management of eyelid malignancies: an evidence-based update. Ophthalmology 2001 108:2088 100.
6. Faustina M, Diba R, Ahmadi A, et al. Patterns of regional and distant metastasis in patients with eyelid and periocular squamous cell carcinoma. Ophthalmology 2004 111:1930 2.
7. Leibovitch I, Huilgol S, Selva D, et al. Cutaneous squamous cell carcinoma treated with Mohs micrographic surgery in Australia. II. Perineural invasion. J Am Acad Dermatol 2005 53:261 6.
8. Esmaeli B, Ahmadi A, Gillenwater A, et al. The role of supraorbital nerve biopsy in cutaneous malignancies of the periocular region. Ophthal Plast Reconstruct Surg 2003 19:282 6.
9. Cockerham KP, Bejjani GK, Kennerdell JS, et al. Surgery for orbital tumors. Part II: transorbital approaches. Neurosurg Focus 2001 10:E3.
10. McLaughlin RB, Montone KT, Wall SJ, et al. Nerve cell adhesion molecule expression in squamous cell carcinoma of the head and neck: a predictor of propensity toward perineural spread. Laryngoscope 1999 109:821 6.
11. Vural E, Hutcheson J, Korourian S, et al. Correlation of neural cell adhesion molecules with perineural spread of squamous cell carcinoma of the head and neck. Otolaryngol Head Neck Surg 2000 122:717 20.
12. Anderson TD, Feldman M, Weber RS, et al. Tumor deposition of laminin-5 and the relationship with perineural invasion. Laryngoscope 2001 111:2140 43.
13. Marks R. Squamous cell carcinoma. Lancet 1996 347:735 8.
14. Valenzuela AA, Whitehead KJ, Sullivan TJ. Ocular adnexal pseudo-cyst formation as a characteristic feature of perineural spread in squamous cell carcinoma. Ophthal Plast Reconstruct Surg 2006 22:201 5.
15. Bowyer JD, Sullivan TJ, Whitehead KJ, et al. The management of perineural spread of squamous cell carcinoma to the ocular adnexae. Ophthal Plast Reconstruct Surg 2003 19:275 81.
16. Esmaeli B, Ginsberg L, Goepfert H, et al. Squamous cell carcinoma with perineural invasion presenting as a Tolosa-Hunt-like syndrome: a potential pitfall in diagnosis. Ophthal Plast Reconstruct Surg 2000 16:450 2.
17. Zeynel KA, Toth J. Relation between p53 overexpression and clinical behavior of ocular/orbital invasion of conjunctival squamous cell carcinoma. Ophthal Plast Reconstruct Surg 2000 16:443 9.
18. Yeudall WA, Jakus J, Ensley JF, et al. Functional characterization of p53 molecules expressed in human squamous cell carcinomas of the head and neck. Mol Carcinogen 1997 18:89 96.
19. Reszec J, Sulkowska M, Kanczuga-Koda L, et al. Evaluation of apoptosis markers in conjunctival and eyelid benign and malignant tumors. Ann N Y Acad Sci 2003 1010:748 51.
20. Reh DD, Lu S, Cohen JI, et al. Alterations in the TGF-B signaling pathway in human head and neck squamous cell carcinoma. Otolaryngol Head Neck Surg 2004 131:P111.
21. Kurtz KA, Hoffman HT, Zimmerman MB, et al. Decreased E-cadherin but not β-catenin expression is associated with vascular invasion and decreased survival in head and neck squamous carcinomas. Otolaryngol Head Neck Surg 2006 134:142 6.
22. Frank DK, Szymkowiak B, Hughes CA. Connexin expression and gap junctional intercellular communication in human squamous cell carcinoma of the head and neck. Otolaryngol Head Neck Surg 2006 135:736 43.
23. Leivonen SK, Ala-Aho R, Koli K, et al. Activation of Smad signaling enhances collagenase-3 (MMP-13) expression and invasion of head and neck squamous carcinoma cells. Oncogene 2006 25:2588 600.
24. Alvarez-Suarez ML, Gonzalez Vazquez LO, Barbon Garcia JJ, et al. Collagenase-3 (MMP-13) expression in epithelial cancers of the eyelids. Arch Soc Esp Oftalmol 2004 79:281 8.
25. Fraunfelder FT, Farris HE, Wallace TR. Cryosurgery for ocular and periocular lesions. J Dermatol Surg Oncol 1977 3:422 7.
26. Tuppurainen K. Cryotherapy for eyelid and periocular basal cell carcinomas: outcome in 166 cases over an 8-year period. Graef Arch Clin Exp Ophthalmol 1995 233:205 8.
27. Nouri K, Spencer JM, Taylor JR, et al. Does wound healing contribute to the eradication of basal cell carcinoma following curettage and electrodessication? Dermatol Surg 1000 25:183 88.
28. Inkster C, Ashworth J, Murdoch JR, et al. Oculoplastic reconstruction following Mohs surgery. Eye 1999 13 (Pt 3a):391 2.
29. Nemet AY, Deckel Y, Martin P, et al. Management of periocular basal and squamous cell carcinoma: a series of 485 cases. Am J Ophthalmol 2006 142:293 7.
30. Glatt HJ, Olson JJ, Putterman AM. Conventional frozen sections in periocular basal-cell carcinoma: a review of 236 cases. Ophthal Surg 1992 23:6 8.
31. Rudolph R, Zelac D. Squamous cell carcinoma of the skin. Plast Reconstruct Surg 2004 114:82e 94e.
32. Smith-Zagone MJ, Schwartz MR. Frozen section of skin specimens. Arch Pathol Lab Med 2005 129:1536 43.
33. Ghauri RR, Gunter AA, Weber RA. Frozen section analysis in the management of skin cancers. Ann Plast Surg 1999 43:156 60.
34. Manstein ME, Manstein CH, Smith R. How accurate is frozen section for skin cancers? Ann Plast Surg 2003 50:607 9.
35. Malhotra R, James CL, Selva D, et al. Periocular squamous intraepidermal carcinoma. Ophthalmology 2004 111:1925 9.
36. Brannan PA, Anderson HK, Kersten RC, et al. Bowen disease of the eyelid successfully treated with imiquimod. Ophthal Plast Reconstr Surg 2005 21:321 2.
37. Hengge U, Stark R. Topical imiquimod to treat intraepidermal carcinoma. Arch Dermatol 2001 137:709 11.
38. Wu JK, Siller G, Whitehead K. Treatment of Bowen's disease and basal cell carcinoma of the nose with imiquimod 5% cream. Aust J Dermatol 2003 44:123 5.
39. Patel GK, Goodwin R, Chawla M, et al. Imiquimod 5% cream monotherapy for cutaneous squamous cell carcinoma in situ (Bowen's disease): a randomized, double-blind, placebo-controlled trial. J Am Acad Dermatol 2006 54:1025 32.
40. Tanghetti E, Werschler P. Comparison of 5% 5-fluorouracil cream and 5% imiquimod cream in the management of actinic keratoses on the face and scalp. J Drugs Dermatol 2007 6:144 7.
41. Gupta AK, Davev V, Mcphail H. Evaluation of the effectiveness of imiquimod and 5-fluorouracil for the treatment of actinic keratosis: critical review and meta-analysis of efficacy studies. J Cutan Med Surg 2005 9:209 14.
42. Jereczek-Fossa BA, Krengli M, Orecchia R. Particle beam radiotherapy for head and neck tumors: radiobiological basis and clinical experience. Head Neck 2006 28:750 60.
43. Lukas VanderSpek LA, Pond GR, Wells W, et al. Radiation therapy for Bowen's disease of the skin. Int J Radiat Oncol Biol Phys 2005 63:505 10.
44. Lang PG, Braun MA, Kwatra R. Aggressive squamous carcinomas of the scalp. Dermatol Surg 2006 32:1163 70.
45. Chun M, Kang S, Kim BS, et al. High dose rate interstitial brachytherapy in soft tissue sarcoma: technical aspects and results. Jap J Clin Oncol 2001 31:279 83.
46. Rio E, Bardet E, Ferron C, et al. Interstitial brachytherapy of periorificial skin carcinomas of the face: a retrospective study of 97 cases. Int J Radiat Oncol Biol Phys 2005 63:753 7.
47. Schulte KW, Lippold A, Auras C, et al. Soft x-ray therapy for cutaneous basal cell and squamous cell carcinomas. J Am Acad Dermatol 2005 53:993 1001.
48. Tyers AG. Orbital exenteration for invasive skin tumours. Eye 2006 20:1165 70.
49. Howard GR, Nerad JA, Carter KD, et al. Clinical characteristics associated with orbital invasion of cutaneous basal cell and squamous cell tumors of the eyelid. Am J Ophthalmol 1992 113:123 33.
50. Leibovitch I, McNab A, Sullivan T, et al. Orbital invasion by periocular basal cell carcinoma. Ophthalmology 2005 112:717 23.
51. Goldberg RA, Kim JW, Shorr N. Orbital exenteration: results of an individualized approach. Ophthal Plast Reconstruct Surg 2003 19:229 36.
52. Reifler DM, Hornblass A. Squamous cell carcinoma of the eyelid. Sur Ophthalmol 1986 30:349 65.
53. Nuyens M, Schupbach J, Stauffer E, et al. Metastatic disease to the parotid gland. Otolaryngol Head Neck Surg 2006 135:844 48.
54. Jeong HS, Son YI, Baek CH. The pattern of lymphatic metastasis of malignant tumors in the periorbital area. Am J Otolaryngol Head Neck Med Surg 2006 27:5 8.
55. Vauterin TJ, Veness MJ, Morgan GJ, et al. Patterns of lymph node spread of cutaneous squamous cell carcinoma of the head and neck. Head Neck 2006 28:785 91.
56. Glat PM, Longaker MT, Jelks EB, et al. Periorbital melanocytic lesions: excision and reconstruction in 40 patients. Plast Reconstruct Surg 1998 102:19 27.
57. Sharma V, Benger R, Martin PA. Techniques of periocular reconstruction. Ind J Ophthalmol 2006 54:149 58.
58. Rafii AA, Enepekides DJ. Upper and lower eyelid reconstruction: the year in review. Curr Opin Otolaryngol Head Neck Surg 2006 14:227 33.
59. Holloman EL, Carter KD. Modification of the cutler-beard procedure using donor achilles tendon for upper eyelid reconstruction. Ophthal Plast Reconstruct Surg 2005 21:267 70.
60. Behroozan DS, Goldberg LH. Upper eyelid rotation flap for reconstruction of medial canthal defects. J Am Acad Dermatol 2005 53:635 8.
61. Jelks GW, Glat PM, Jelks EB, et al. Medial canthal reconstruction using a medially based upper eyelid myocutaneous flap. Plast Reconstruct Surg 2002 110:1636 43.
62. Yildirim S, Akoz T, Akan M, et al. The use of combined nasolabial V-Y advancement and glabellar flaps for large medial canthal defects. Dermatol Surg 2001 27:215 8.
63. Meadows AE, Manners RM. A simple modification of the glabellar flap in medial canthal reconstruction. Ophthal Plast Reconstruct Surg 2003 19:313 5.
64. Goldman GD. Rotation flaps. Dermatol Surg 2005 31:1006 13.
65. Copcu E. Trilobed skin flap on the face: for reconstruction of full-thickness or commissural defects. Dermatol Surg 2004 30:915 21.
66. Checcone MA, Wen J, Saigal K, et al. Expression of B7 co-stimulatory molecules in patients with squamous cell carcinoma. Otolaryngol Head Neck Surg 2005 133:P49.
67. Scianna JM, Petruzzelli GJ, Le PL. Head and neck squamous cell carcinoma: the significance of the T-regulatory cell. Otolaryngol Head Neck Surg 2005 133:P142 3.
68. Shen K, Gorti K, Duffey DC. Role of EGFR activation on ERK and ATF2 expression in head and neck squamous cell carcinoma cell lines. Otolaryngol Head Neck Surg 2005 133:P94.
69. Huang SM, Bock JM, Harari PM. Epidermal growth factor receptor blockade with C225 modulates proliferation, apoptosis, and radiosensitivity in squamous cell carcinomas of the head and neck. Cancer Res 1999 59:1935 40.
70. Riedel F, Gotte K, Naim R, et al. Targeting IL-6 expression in human head and neck squamous cell carcinoma decreases proliferation and angiogenic activity. Otolaryngol Head Neck Surg 2005 133:P149.
71. Khafif A, Hurst R, Kyker K, et al. Curcumin: a new radio-sensitizer of squamous cell carcinoma cells. Otolaryngol Head Neck Surg 2005 132:317 21.
72. Arbiser JL, Klauber N, Rohan R, et al. Curcumin is an in vivo inhibitor of angiogenesis. Mol Med 1998 4:376 83.
73. Aggarwal BB, Kumar A, Bharti AC. Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res 2003 23 (1A):363 98.
74. Plummer SM, Holloway KA, Manson MM, et al. Inhibition of cyclo-oxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-κB activation via the NIK/IKK signaling complex. Oncogene 1999 18:6013 20.
75. Cheng AL, Hsu CH, Lin JK, et al. Phase I clinical trial of curcumin, a chemopreventative agent, in patients with high-risk or pre-malignant lesions. Anticancer Res 2001 21 (4B):2895 900.